20 ML lidocaine hydrochloride 15 MG/ML Injection
- RxCUI
- 1737636
- RxNorm name
- 20 ML lidocaine hydrochloride 15 MG/ML Injection
- Display name
- Lidocaine (Injectable)
- Full name
- 20 ML lidocaine hydrochloride 15 MG/ML Injection
- Term type
- SCD
- Status
- Active
- Strength
- 15 mg/ml
- Dose form
- Injection 20 ml
- Route
- Injectable
- Updated
- 2026-10-21 07:30:22
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032016
- Active start
- 032016
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| lidocaine hydrochloride | 15 MG / 1 ML | lidocaine | lidocaine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| lidocaine | 6387 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 20 ML lidocaine hydrochloride 15 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 20 ML lidocaine hydrochloride 15 MG/ML Injection | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1737636 | 1 | CODES |
| MMSL_CODE | BD14942 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0409-4776-01 | 0409-4776 | Lidocaine Hydrochloride LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ANDA080408 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA080408 | 0409-4776 | Lidocaine Hydrochloride LIDOCAINE HYDROCHLORIDE | ANDA | Hospira, Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xylocaine MPF | LIDOCAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | d5e0d06f-ba1e-44d4-aa89-39d6c146dc23 | 2024-05-13 | Warnings, Adverse reactions | 1737636 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3b2dd84e-cee8-4e58-d494-395a65a353a0 | lidocaine HCl 1.5 % in 20 ML Injection [PSN] · 20 ML lidocaine hydrochloride 15 MG/ML Injection [SCD] · lidocaine HCl 1.5 % per 20 ML Injection [SY] · lidocaine HCl 300 MG per 20 ML Injection [SY] | 4 | 46 | These highlights do not include all the information needed to use LIDOCAINE HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for LIDOCAINE HYDROCHLORIDE INJECTION, USP. LIDOCAINE HYDROCHLORIDE INJECTION, USP, aqueous solutions for infiltration and nerve block Initial U.S. Approval: 1948 | 20260116 |
| d5e0d06f-ba1e-44d4-aa89-39d6c146dc23 | lidocaine HCl 1.5 % in 20 ML Injection [PSN] · 20 ML lidocaine hydrochloride 15 MG/ML Injection [SCD] · lidocaine HCl 1.5 % per 20 ML Injection [SY] · lidocaine HCl 300 MG per 20 ML Injection [SY] | 4 | 13 | Xylocaine MPF (lidocaine HCl Injection USP) Xylocaine MPF (lidocaine HCl and epinephrine Injection USP) | 20240513 |
| e3f67ed9-d041-433d-9386-7897b51e3381 | lidocaine HCl 1.5 % in 20 ML Injection [PSN] · 20 ML lidocaine hydrochloride 15 MG/ML Injection [SCD] · lidocaine HCl 1.5 % per 20 ML Injection [SY] · lidocaine HCl 300 MG per 20 ML Injection [SY] | 4 | 4 | General Surgery Kit | 20120312 |
| a3c7fad5-48f2-42d0-86d6-0d5818648c2c | lidocaine HCl 1.5 % in 20 ML Injection [PSN] · 20 ML lidocaine hydrochloride 15 MG/ML Injection [SCD] · lidocaine HCl 1.5 % per 20 ML Injection [SY] · lidocaine HCl 300 MG per 20 ML Injection [SY] | 4 | 1 | Cardiovascular Procedure Kit | 20120314 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3b2dd84e-cee8-4e58-d494-395a65a353a0 | These highlights do not include all the information needed to use LIDOCAINE HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for LIDOCAINE HYDROCHLORIDE INJECTION, USP. LIDOCAINE HYDROCHLORIDE INJECTION, USP, aqueous solutions for infiltration and nerve block Initial U.S. Approval: 1948 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20261019 |
| 3b2dd84e-cee8-4e58-d494-395a65a353a0 | These highlights do not include all the information needed to use LIDOCAINE HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for LIDOCAINE HYDROCHLORIDE INJECTION, USP. LIDOCAINE HYDROCHLORIDE INJECTION, USP, aqueous solutions for infiltration and nerve block Initial U.S. Approval: 1948 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260805 |
| 3b2dd84e-cee8-4e58-d494-395a65a353a0 | These highlights do not include all the information needed to use LIDOCAINE HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for LIDOCAINE HYDROCHLORIDE INJECTION, USP. LIDOCAINE HYDROCHLORIDE INJECTION, USP, aqueous solutions for infiltration and nerve block Initial U.S. Approval: 1948 | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260116 |
| 3b2dd84e-cee8-4e58-d494-395a65a353a0 | Lidocaine Hydrochloride Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20251005 |
| 3b2dd84e-cee8-4e58-d494-395a65a353a0 | Lidocaine Hydrochloride Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20241203 |
| 284dee3b-cfeb-4098-b12d-46068bc1971f | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20161019 | |
| 3512ffcc-f347-4eec-b23a-f37c4c895460 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20161018 | |
| fc46099b-ff33-4eda-876e-db49c5055fbd | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20161017 | |
| 43def7ec-e8e0-4cde-9658-1bd1f14a7cf1 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20161011 | |
| 0ff5394b-dde1-4e3c-9ceb-c8f06d8cff6f | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20161003 | |
| a71ff522-4cfb-4562-ae73-775882bec106 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20160926 | |
| 922bccb5-3008-425b-9f20-924102965c04 | Smiths Medical ASD, Inc. | Hospira, Inc. | 20160823 | |
| 16b64c7f-b70a-4192-b4b8-b0c941891c1d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 3M Company | 20160809 | |
| c5cdd03c-8467-4544-9729-9434f3c31769 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 20160628 | |
| d52f704d-824d-4199-ba4c-9258b71695d5 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20160620 | |
| d7be6178-f6e9-455c-949a-ae195ba35a55 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20150630 | |
| fdce95a7-ef0a-499b-b660-d291364092eb | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20150513 | |
| 0dd54707-a97b-44df-aae7-cd65f79d158d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 20140430 | |
| ea4d9094-1aca-4c0f-a67d-7276a9fd591b | Smiths Medical ASD, Inc. | Hospira, Inc. | CareFusion 213 LLC | Kwang Myung Pharm. Co., Ltd. | 20140408 | |
| e42b0f73-fc83-4e0d-b6ba-5bf97e410c2b | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130905 | |
| aa8347f5-8890-452b-9b8b-f54efcea55e4 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | 20130104 | |
| 88d319dd-a6e8-4809-8fdd-b140ec4e6291 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130104 | |
| 3e19aac6-7a5c-428b-a700-42ac3b85ef1d | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130104 | |
| 337c3875-d6d1-4491-9e28-872b88d29065 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130103 | |
| dc352061-6037-4291-9b9a-f5f0343efa44 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20130103 | |
| 3f1a31ae-8cfe-415a-b646-de4d17b0f4e3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 20121210 | |
| fe2a1277-0434-4ffc-af1c-2e8fdaf876d5 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121127 | |
| ce8d1ecd-7af7-4daa-b843-7a0c7a8ec6e3 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20121016 | |
| 0faf2c3c-899c-4d13-ab73-b5179e30ed25 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120928 | |
| 8128ed2a-e65f-4125-a5fe-71a223450029 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120820 | |
| 10eb982c-d0ce-469d-b6c8-10133acd3720 | Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | Kwang Myung Pharm. Co., Ltd. | 20120814 | |
| 0256af4a-f82e-4b20-a63b-6f3c9c07c9c8 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120813 | |
| 9b1f8dd9-b637-489d-8e3b-d3171fbb71ba | National Council for Prescription Drug Programs | 20120724 | |
| 6fa83996-9e01-40c7-a4ff-76812f2d810c | National Council for Prescription Drug Programs | 20120724 | |
| d15dd2e2-a783-4c48-a1f4-792bd5e1f623 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120719 | |
| a82c1666-ffdd-497c-8fd6-126a6c727db2 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120717 | |
| 76470d10-a834-4ddf-a05e-25fafb158741 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120716 | |
| f0b60ec1-3fbc-4130-9235-22dcc96f8219 | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120508 | |
| 3d57dca4-170d-424b-96b4-4e365d02043e | Smiths Medical ASD, Inc. | Hospira, Inc. | 20120413 | |
| b7f546f3-ed5f-4a7f-b9b1-1f5c3ebef0ea | Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc. | 20120410 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | lidocaine | |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | lidocaine | |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | lidocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | lidocaine | |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | lidocaine | |
| ATC | S01HA | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | lidocaine | |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine hydrochloride |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D018754 | Ventricular Dysfunction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine hydrochloride |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 15 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 20 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA080408 |
| CODES | VUID | 4015605 |
| NAMES | Prescribable Synonym | lidocaine HCl 1.5 % in 20 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |